Concepedia

Gregory Locke

GL

15

Publications

509

Citations

14

H-Index

2000

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Wilmington University

DuPont (United States)

Gregory Locke is an author at Bristol-Myers Squibb (United States) specializing in biochemistry, natural sciences, and chemical biology.

Top concepts

Publications per year

2000–2023

15

Publications

15

Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor

Dan You, Stephen Hillerman, Gregory Locke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 75 citations · Full text

Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor

Aiying Wang, Charles R. Dorso, Lisa M. Kopcho et al. · BMC Pharmacology · 2012 · 59 citations · Full text

Expression, purification, and characterization of human and rat acetyl cfenzyme A carboxylase (ACC) isozymes

Dongmei Cheng, Ching-Hsuen Chu, Luping Chen et al. · Protein Expression and Purification · 2006 · 53 citations

, , +4

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1

Andrew P. Degnan, Godwin Kumi, Christopher W. Allard et al. · ACS Medicinal Chemistry Letters · 2021 · 51 citations · Full text

A Second Dihydroorotate Dehydrogenase (Type A) of the Human Pathogen Enterococcus faecalis: Expression, Purification, and Steady-State Kinetic Mechanism

Jovita Marcinkeviciene, Wenjun Jiang, Gregory Locke et al. · Archives of Biochemistry and Biophysics · 2000 · 33 citations

, , +5

Rows per page

1–5 of 15